Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...
“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...
RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...
Just over a month into the new year, influenza season is hitting hard in the Southland, and the flu isn't the only virus ...
LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...